Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 6 articles:
HTML format
Text format



Single Articles


    May 2018
  1. MARVASO G, Viola A, Fodor C, Jereczek-Fossa BA, et al
    Radiotherapy Plus Total Androgen Block Versus Radiotherapy Plus LHRH Analog Monotherapy for Non-metastatic Prostate Cancer.
    Anticancer Res. 2018;38:3139-3143.
    PubMed     Text format     Abstract available


  2. SLETTEN ET, Arnes M, Vereide AB, Orbo A, et al
    Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study.
    Anticancer Res. 2018;38:2883-2889.
    PubMed     Text format     Abstract available


    November 2017
  3. YANG Y, Li X, Mamouni K, Kucuk O, et al
    Mifepristone Has Limited Activity to Enhance the In Vivo Efficacy of Docetaxel and Enzalutamide Against Bone Metastatic and Castration-Resistant Prostate Cancer.
    Anticancer Res. 2017;37:6235-6243.
    PubMed     Text format     Abstract available


    May 2017
  4. SLETTEN ET, Arnes M, Lysa LM, Moe BT, et al
    Prediction of Relapse After Therapy Withdrawal in Women with Endometrial Hyperplasia: A Long-term Follow-up Study.
    Anticancer Res. 2017;37:2529-2536.
    PubMed     Text format     Abstract available


    April 2017
  5. BRADY PC, Soiffer RJ, Ginsburg ES
    Continuation of a Levonorgestrel Intrauterine Device During Hematopoietic Stem Cell Transplant: A Case Report.
    Anticancer Res. 2017;37:1985-1987.
    PubMed     Text format     Abstract available


    December 2016
  6. CHECK JH, Check D, Wilson C, Lofberg P, et al
    Long-term High-quality Survival with Single-agent Mifepristone Treatment Despite Advanced Cancer.
    Anticancer Res. 2016;36:6511-6513.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: